RenaissanceRe (RNR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
18 Mar, 2026Executive summary
Achieved strong financial results in 2025, including $2.6B net income and 26% return on average common equity, despite significant catastrophe losses from California Wildfires and specialty events.
All three profit drivers—underwriting, fee, and investment income—contributed, with $1.3B underwriting income, $328.9M fee income, and $1.7B investment income.
Repurchased $1.6B in common shares, reflecting confidence in long-term earnings and capital stewardship.
Grew to over 1,000 employees, emphasizing leadership development, succession planning, and retention.
Board and management focused on long-term value creation, entering 2026 with a strong balance sheet and diversified platform.
Voting matters and shareholder proposals
Four Class I director nominees up for election to serve until 2029; Board recommends voting FOR all nominees.
Advisory vote on executive compensation (say-on-pay); Board recommends FOR.
Approval of the 2026 Long-Term Incentive Plan; Board recommends FOR.
Approval of PricewaterhouseCoopers Ltd. as independent auditor for 2026 and referral of remuneration to the Board; Board recommends FOR.
Board of directors and corporate governance
Board is 91% independent, with 45% diversity and an average tenure of 8 years.
Recent refreshment: four new directors in four years, including nominee Stephen C. Hooley.
Board committees are fully independent; regular rotation of committee chairs and members.
Board oversight includes strategic planning, risk management, CEO succession, and sustainability.
Majority vote standard for director elections; robust Code of Ethics and anti-hedging/pledging policies.
Latest events from RenaissanceRe
- Key votes include director elections, executive pay, incentive plan, and auditor appointment.RNR
Proxy Filing18 Mar 2026 - Net income hit $2.65B in 2025, with 30.8% book value growth despite major loss events.RNR
Q4 20254 Feb 2026 - Q2 2024 saw $495M net income, 29% premium growth, and strong returns from Validus.RNR
Q2 20242 Feb 2026 - Q3 net income soared to $1.17B, with strong premium growth and investment gains.RNR
Q3 202415 Jan 2026 - Record $2.2B operating income and 26% tangible book value growth despite catastrophe losses.RNR
Q4 20249 Jan 2026 - Catastrophe losses led to an operating loss, but investment gains and capital strength persisted.RNR
Q1 202520 Dec 2025 - 2024 saw record growth, strategic integration, and enhanced governance, with all proposals recommended for approval.RNR
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, and auditor approval for 2025.RNR
Proxy Filing2 Dec 2025 - Q2 2025 net income rose 67% with a 75.1% combined ratio and strong book value growth.RNR
Q2 20255 Nov 2025